Published in CA Cancer J Clin on June 30, 2004
A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res (2006) 4.28
Triple-negative breast cancers are increased in black women regardless of age or body mass index. Breast Cancer Res (2009) 2.23
Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer (2008) 2.23
Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J (2007) 1.84
Breast cancer incidence patterns among California Hispanic women: differences by nativity and residence in an enclave. Cancer Epidemiol Biomarkers Prev (2010) 1.56
Advanced breast cancer incidence following population-based mammographic screening. Ann Oncol (2011) 1.53
Variation in tumor natural history contributes to racial disparities in breast cancer stage at diagnosis. Breast Cancer Res Treat (2013) 1.53
Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women? Cancer Causes Control (2013) 1.46
A matter of race: early-versus late-stage cancer diagnosis. Health Aff (Millwood) (2009) 1.38
Causes of death and relative survival of older women after a breast cancer diagnosis. J Clin Oncol (2011) 1.36
Epidemiology of ductal carcinoma in situ. J Natl Cancer Inst Monogr (2010) 1.33
The impact of breast reconstruction on the delivery of chemotherapy. Cancer (2010) 1.20
Triple-negative breast cancer and obesity in a rural Appalachian population. Cancer Epidemiol Biomarkers Prev (2008) 1.20
Racial disparities and trends in radiation therapy after breast-conserving surgery for early-stage breast cancer in women, 1992 to 2002. Ethn Dis (2007) 1.15
Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat (2008) 1.15
Race and age disparities in receipt of sentinel lymph node biopsy for early-stage breast cancer. Breast Cancer Res Treat (2011) 1.13
Can differences in breast cancer utilities explain disparities in breast cancer care? J Gen Intern Med (2006) 1.12
Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale. Carcinogenesis (2011) 1.10
Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis. Ont Health Technol Assess Ser (2010) 1.01
Racial/ethnic differences in early detection of breast cancer: a study of 250,985 cases from the California Cancer Registry. J Womens Health (Larchmt) (2010) 1.01
Racial disparities in the development of breast cancer metastases among older women: a multilevel study. Cancer (2009) 1.00
Pattern of presentation and survival of breast cancer in a teaching hospital in north Western Nigeria. Oman Med J (2010) 1.00
Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico. Cancer Genet (2012) 0.95
Factors associated with delayed diagnosis of breast cancer in northeast Thailand. J Epidemiol (2013) 0.92
Clinical utility of microarrays: current status, existing challenges and future outlook. Curr Genomics (2008) 0.89
The Evaluation of p53 Polymorphism at Codon 72 and Association With Breast Cancer in Iran: A Systematic Review and Meta-analysis. J Cancer Prev (2016) 0.89
Does architectural lighting contribute to breast cancer? J Carcinog (2006) 0.89
Reproductive factors and risk of premenopausal breast cancer by age at diagnosis: are there differences before and after age 40? Breast Cancer Res Treat (2013) 0.89
Family history of cancer and risk of breast cancer in the Black Women's Health Study. Cancer Causes Control (2009) 0.85
Breast cancer screening practices among first-generation immigrant muslim women. J Womens Health (Larchmt) (2014) 0.84
Clinical, sociodemographic, and local system factors associated with a hospital death among cancer patients. Support Care Cancer (2005) 0.83
Genetic polymorphisms in RAD23B and XPC modulate DNA repair capacity and breast cancer risk in Puerto Rican women. Mol Carcinog (2013) 0.83
Synthetic progestins differentially promote or prevent 7,12-dimethylbenz(a)anthracene-induced mammary tumors in sprague-dawley rats. Cancer Prev Res (Phila) (2010) 0.82
Knowledge of breast density and awareness of related breast cancer risk. J Cancer Educ (2013) 0.81
Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer. BMC Cancer (2012) 0.81
Effect of a Targeted Women's Health Intervention in an Inner-City Emergency Department. Emerg Med Int (2011) 0.79
Racial differences in the use of adjuvant chemotherapy for breast cancer in a large urban integrated health system. Int J Breast Cancer (2012) 0.79
Factors associated with place of death of cancer patients in the Mexico City Metropolitan area. Support Care Cancer (2006) 0.79
A model building exercise of mortality risk for Taiwanese women with breast cancer. BMC Med Inform Decis Mak (2010) 0.79
Incidence, mortality and survival of female breast cancer during 2003-2011 in Jiangsu province, China. Chin J Cancer Res (2016) 0.78
Patient and tumor characteristics associated with breast cancer recurrence after complete pathological response to neoadjuvant chemotherapy. Breast Cancer Res Treat (2012) 0.78
Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women. ISRN Oncol (2013) 0.78
Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: a comparative study between Texas Cancer Registry and National Cancer Institute's Surveillance, Epidemiology and End Results data. Int J Oncol (2015) 0.77
Cryosurgery of breast cancer. Gland Surg (2012) 0.77
Factors that influence the incidence of breast cancer in Arica, Chile (Review). Oncol Lett (2010) 0.76
Insulin-like growth factor 1 gene polymorphism and breast cancer risk among arab omani women: a case-control study. Breast Cancer (Auckl) (2012) 0.76
Variations in time to receiving first surgical treatment for breast cancer as a function of racial/ethnic background: a cohort study. JRSM Open (2014) 0.76
Prediction of anticancer peptides against MCF-7 breast cancer cells from the peptidomes of Achatina fulica mucus fractions. Comput Struct Biotechnol J (2015) 0.75
Differential expression of DNA repair genes in Hispanic women with breast cancer. Mol Cancer Biol (2013) 0.75
To be young, Black, and living with breast cancer: a systematic review of health-related quality of life in young Black breast cancer survivors. Breast Cancer Res Treat (2016) 0.75
The Study of DNA Methylation of bax Gene Promoter in Breast and Colorectal Carcinoma Cell Lines. Iran J Cancer Prev (2013) 0.75
The impact of breast cancer knowledge and attitudes on screening and early detection among an immigrant Iranian population in southern California. J Relig Health (2014) 0.75
A comparison of breast and cervical cancer legislation and screening in Georgia, North Carolina, and South Carolina. J Health Care Poor Underserved (2012) 0.75
Are there disparities in the presentation, treatment and outcomes of patients diagnosed with medullary thyroid cancer?-An analysis of 634 patients from the California Cancer Registry. Gland Surg (2016) 0.75
Global cancer statistics. CA Cancer J Clin (2011) 185.92
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Cancer statistics, 2012. CA Cancer J Clin (2012) 87.38
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Cancer statistics, 2013. CA Cancer J Clin (2013) 84.72
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Cancer statistics, 2014. CA Cancer J Clin (2014) 72.81
Cancer statistics, 2015. CA Cancer J Clin (2015) 57.51
Global cancer statistics, 2012. CA Cancer J Clin (2015) 53.52
Cancer statistics, 2007. CA Cancer J Clin (2007) 53.49
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin (2011) 30.81
Cancer statistics, 2006. CA Cancer J Clin (2006) 30.71
Cancer statistics, 2005. CA Cancer J Clin (2005) 25.65
Cancer statistics, 2004. CA Cancer J Clin (2004) 15.72
Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin (2012) 14.47
Cancer statistics, 2003. CA Cancer J Clin (2003) 13.46
Colorectal cancer statistics, 2014. CA Cancer J Clin (2014) 12.86
Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin (2004) 12.55
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Cancer statistics, 2002. CA Cancer J Clin (2002) 10.79
Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer (2004) 9.24
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst (2005) 8.36
Trends in the leading causes of death in the United States, 1970-2002. JAMA (2005) 8.20
Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control. J Natl Cancer Inst (2008) 8.14
International variation in prostate cancer incidence and mortality rates. Eur Urol (2012) 8.04
21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med (2013) 7.77
Breast cancer statistics, 2013. CA Cancer J Clin (2013) 7.35
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst (2003) 7.06
Long-term ozone exposure and mortality. N Engl J Med (2009) 6.90
Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer (2007) 6.84
Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol (2012) 6.37
Breast cancer statistics, 2011. CA Cancer J Clin (2011) 6.12
Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer (2002) 6.08
Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin (2007) 5.67
A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 5.62
Increasing incidence of differentiated thyroid cancer in the United States, 1988-2005. Cancer (2009) 5.55
Association of insurance with cancer care utilization and outcomes. CA Cancer J Clin (2007) 5.31
Annual report to the nation on the status of cancer, 1975-2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst (2011) 5.09
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement. Lancet Oncol (2009) 5.05
Cancer mortality in the United States by education level and race. J Natl Cancer Inst (2007) 4.77
Cancer screening in the United States, 2010: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2010) 4.76
Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin (2006) 4.73
Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer (2006) 4.71
Worldwide variations in colorectal cancer. CA Cancer J Clin (2009) 4.71
International trends in colorectal cancer incidence rates. Cancer Epidemiol Biomarkers Prev (2009) 4.49
Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet (2016) 4.49
Annual number of lung cancer deaths potentially avertable by screening in the United States. Cancer (2013) 4.24
Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012) 4.13
Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin (2007) 4.09
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93
The global burden of cancer: priorities for prevention. Carcinogenesis (2009) 3.73
Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin (2014) 3.59
Cancer statistics for Hispanics/Latinos, 2012. CA Cancer J Clin (2012) 3.58
Annual Report to the Nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer (2012) 3.55
Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group. J Clin Oncol (2003) 3.51
American Cancer Society guidelines for the early detection of cancer, 2006. CA Cancer J Clin (2006) 3.46
Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int (2008) 3.45
Lung cancer rates in men and women with comparable histories of smoking. J Natl Cancer Inst (2004) 3.43
Cancer screening in the United States, 2009: a review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2009) 3.25
Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res (2007) 3.23
Increase in incidence of colorectal cancer among young men and women in the United States. Cancer Epidemiol Biomarkers Prev (2009) 3.08
Under-use of smoking-cessation treatments: results from the National Health Interview Survey, 2000. Am J Prev Med (2005) 3.02
American Cancer Society guidelines for the early detection of cancer. CA Cancer J Clin (2002) 2.94
American Cancer Society guidelines for the early detection of cancer, 2003. CA Cancer J Clin (2003) 2.91
Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues. CA Cancer J Clin (2008) 2.80
Cancer screening in the United States, 2011: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin (2011) 2.76
Lung cancer death rates in lifelong nonsmokers. J Natl Cancer Inst (2006) 2.66
All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959-1996. Am J Epidemiol (2002) 2.64
Racial disparities in stage-specific colorectal cancer mortality rates from 1985 to 2008. J Clin Oncol (2011) 2.58
Burden of cervical cancer in the United States, 1998-2003. Cancer (2008) 2.57
Racial and ethnic disparities in smoking-cessation interventions: analysis of the 2005 National Health Interview Survey. Am J Prev Med (2008) 2.50